SN
Sibannac, Inc.
SNNC · OTC
$0.00 -2.54% (-$0.00)
1M -22.03%
Market Cap $154.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 28.07x
EV/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 5,323.67%
Op. margin 4,896.64%
FCF margin 649.09%
Quality
57 /100
Average ROA 38.12%
Asset turnover 0.01x
ROIC 313.13%
Debt
0 /100
High Int. coverage -9.37x
Current ratio 0.05x
Net debt/EBITDA N/A
Stability
25 /100
Unstable Beta 1.61x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SNNC
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
David A. Mersky
Employees
1
Headquarters
Phoenix